Dr. Richard T. Silver was an invited lecturer at the "Leukemia and Lymphoma: East and West are Together" Conference sponsored by the M.D. Anderson Cancer Center, held in Dubrovnik, Croatia from September 16-21. He spoke about the treatment of polycythemia vera with interferon.
Dr. Manish Shah has pursued a career in Medical Oncology with a primary focus on clinical translational medicine in GI Oncology that melds his research experience at the bench with patient care.
A molecular trigger involved in lung regeneration has been uncovered. Investigators – including Dr. Ronald G. Crystal (Chief of Pulmonary and Critical Care Medicine) and Dr. Shahin Rafii (Professor of Medicine/Medicine & Genetics) – have published their findings in Cell. The discovery is part of a labyrinth of advances toward a fuller understanding of the process of lung regeneration.
Beloved by patients, colleagues, and friends alike, Dr. Anne Moore has long been recognized for her pioneering career and her devotion to patient care in the field of breast cancer. She was honored on June 1, 2011 with the Maurice R. Greenberg Distinguished Service Award.
Dr. Mohamad F. Jamiluddin, a former fellow in the Division of Hematology and Medical Oncology, obtained a patent and produced several research papers in the field of HIV-AIDS within his first two years of training. His journey – emigrating from India to America – is featured in a documentary premiering on HBO, July 4, 2011.
Anne Moore, M.D., Professor of Clinical Medicine and Medical Director of the Weill Cornell Breast Center, will be honored by The New York Academy of Medicine with the 2011 Academy Plaque for Exceptional Service to the Academy. Dr. Moore specializes in the research and treatment of breast cancer.
Acute myelogenous leukemia (AML), with more than 12,000 new diagnoses each year, is a particularly stealthy cancer. But a team of researchers led by Ari M. Melnick, M.D., Associate Professor of Medicine at Weill Cornell Medical College, have caught it in the act.
Research from the laboratory of Ari M. Melnick, M.D. has resulted in a promising new combinatorial therapy for diffuse large B cell lymphoma, an aggressive and rapidly progressive cancer that affects approximately 21,000 new people each year. This research, published in The Journal of Clinical Investigation, may hold significant implications for patient survival rates.
Monica L. Guzman, Ph.D., Assistant Professor of Pharmacology in Medicine, Weill Cornell Medical College, is among this year's recipients of the National Institutes of Health Director's New Innovator Awards. Established in 2008 to stimulate highly innovative research and support promising new investigators, the five-year award is for $1.5 million.
This award is presented annually to members of the Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research. The award has been generously supported by the Michael Wolk Foundation.
